Karlin et al 1 reviewed 20 cases of noncardiac acute respiratory failure during G-CSF-induced recovery from neutropenia and concluded that patients with pulmonary infiltrates during neutropenia are at risk of developing acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) during G-CSF-induced neutrophil recovery.
In their discussion, the authors state that G-CSF upregulates the production of cytokines that increase alveolar permeability or neutrophil influx, such as TNF-a, IL-1b, and IL-8. 1 We have previously shown that endogenous levels of G-CSF may be important for accumulation and activation of neutrophils in patients with ARDS. In this process of neutrophil influx, local G-CSF production rather than elevated circulating G-CSF levels seems to be the likely driving force. 2 The question of whether the cytokine-releasing capacity of whole blood is altered by G-CSF was addressed in a study in which blood obtained from healthy volunteers treated with G-CSF was incubated ex vivo with lipopolysaccharide (LPS), and LPS-inducible release of cytokines and soluble receptors was measured. Levels of TNF-a were found to be reduced, whereas those of IL-6, IL-10, and soluble TNF-a receptor types I and II (sTNFRI, sTNFRII) were increased, indicating a G-CSF-induced shift towards anti-inflammatory cytokine response. 3 In a clinical study of human volunteers, treatment with G-CSF 2 h prior to being administered with LPS resulted in an increased release of TNF-a, IL-6, IL-1 receptor antagonist (IL-1RA), sTNFRI, and sTNFRII, whereas treatment with G-CSF 24 h before being inoculated with LPS resulted in attenuating, although to a modest extent, systemic TNF-a levels, and increased serum concentrations of IL-1RA, as well as sTNFRI and sTNFRII. 4 An in vitro study of human polymorphonucleated neutrophils isolated from peripheral blood showing low but detectable expression levels of IL-1RA transcripts, which were considerably augmented after treatment with LPS and G-CSF, provides evidence supporting the role of G-CSF in promoting anti-inflammatory cytokine production. 5 In patients with ALI and ARDS, we have shown significant positive correlation of alveolar G-CSF levels with those of IL-6, sTNFRII, and IL-1RA, and of serum G-CSF levels with those of serum IL-6, IL-1RA, and IL-10. 6 These studies suggest that G-CSF plays a role in the upregulation of anti-inflammatory mediators despite its potential in aggravating lung injury.
In view of the anti-inflammatory properties of G-CSF, it is unclear whether upregulation of the production of cytokines that increase alveolar permeability or neutrophil influx are the sole contributory factors for development of ALI and ARDS seen in G-CSF-induced neutrophil recovery or whether other factors contribute.
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